8-K: Trans American Aquaculture Secures $104,000 Investment via Securities Purchase Agreement

Sentiment:

Current Report (8-K)


Trans American Aquaculture enters into a Securities Purchase Agreement with GHS Investments LLC, potentially raising up to $104,000 through the sale of Series D Preferred Stock and warrants.

Capital raiseTrans American Aquaculture has entered into a Securities Purchase Agreement with GHS Investments LLC.The agreement allows the company to sell up to 104 shares of Series D Preferred Stock for an aggregate of up to $104,000.At the initial closing, GHS purchased 36 shares and received 10 commitment shares.The company may sell up to an additional 68 shares in future closings.

Summary

  • Trans American Aquaculture, Inc. entered into a Securities Purchase Agreement (SPA) with GHS Investments LLC on March 28, 2025.
  • Under the SPA, the Company may sell up to 104 shares of Series D Preferred Stock to GHS for an aggregate of up to $104,000 ($1,000 per share).
  • At the initial closing on March 28, 2025, GHS purchased 36 shares of Series D Preferred Stock and received an additional 10 shares as commitment shares.
  • The Company may sell and GHS may purchase up to an additional 68 shares of Series D Preferred Stock in subsequent closings, subject to the terms of the SPA.
  • With each closing, the Company will issue warrants to GHS to purchase Common Stock equal to 50% of the number of Conversion Shares issuable upon conversion of the Series D Preferred Stock, with an exercise price of 115% of the closing bid price the day before issuance.
  • At the initial closing, the Company issued warrants to purchase up to 306,666,667 shares of Common Stock exercisable at $0.000115 per share, expiring on March 28, 2030.
  • The sales of Series D Preferred Stock and warrants were made in reliance on Rule 506(b) of Regulation D under the Securities Act of 1933.

Sentiment

Score: 5

Explanation: The announcement is neutral. It details a financing agreement which provides capital but also introduces potential dilution.

Positives

  • The Securities Purchase Agreement provides Trans American Aquaculture with a potential influx of up to $104,000.
  • The initial closing provides immediate capital of $36,000 plus commitment shares.
  • The warrants issued to GHS could incentivize future investment and increase the company's market capitalization if exercised.

Negatives

  • The issuance of a large number of warrants (306,666,667) could dilute existing shareholders' equity if exercised.
  • The exercise price of the warrants is very low ($0.000115), which could lead to significant dilution.
  • The company is relying on Regulation D for the sale of securities, indicating that the securities are not registered and may have limited liquidity.

Risks

  • The company's ability to sell the remaining 68 shares of Series D Preferred Stock depends on GHS's willingness to purchase them.
  • The exercise of the warrants is contingent on the market price of the company's common stock exceeding the exercise price of $0.000115.
  • The company's reliance on Regulation D for the sale of securities may limit the pool of potential investors in the future.

Future Outlook

The company may sell up to an additional 68 shares of Series D Preferred Stock to GHS in future closings, subject to the terms of the SPA.

Management Comments

  • Adam Thomas, Chief Executive Officer, signed the report on behalf of Trans American Aquaculture, Inc.

Industry Context

Small aquaculture companies often seek funding through private placements like this to finance operations and expansion. The terms, including the warrants, are typical for such agreements with small cap companies.

Comparison to Industry Standards

  • Similar private placements in the aquaculture industry often involve the issuance of preferred stock and warrants to attract investors.
  • The warrant coverage of 50% of the conversion shares is within the typical range for these types of deals.
  • The low exercise price of the warrants suggests that the company's stock is currently trading at a very low valuation.

Stakeholder Impact

  • Shareholders may experience dilution if the warrants are exercised.
  • The company's employees and customers may benefit from the additional capital infusion.
  • Creditors may view the capital raise positively as it improves the company's financial stability.

Next Steps

  • The company may proceed with additional closings to sell the remaining 68 shares of Series D Preferred Stock to GHS.
  • GHS may exercise its warrants to purchase Common Stock, depending on the market price.
  • The company will need to manage the potential dilution from the warrant exercises.

Key Dates

DateDescription
2025-03-28Date of Securities Purchase Agreement and initial closing.
2030-03-28Expiration date of warrants.
2025-04-03Date of report.

Keywords

Securities Purchase Agreement, Series D Preferred Stock, Warrants, GHS Investments LLC, Capital Raise, Regulation D, Trans American Aquaculture

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.